Bioequivalence Following Buccal and??Sublingual Placement of Fentanyl??Buccal Tablet 400????g in??Healthy Subjects
Authors:
- 1 January 2008
- journal article
- research article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 28 (1) , 1-7
Abstract
Background and objective: The fentanyl buccal tablet (FBT) is formulated to enhance the rate and extent of fentanyl absorption across the buccal mucosa. FBT is indicated for the management of...Keywords
This publication has 12 references indexed in Scilit:
- Single‐Dose and Steady‐State Pharmacokinetics of Fentanyl Buccal Tablet in Healthy VolunteersThe Journal of Clinical Pharmacology, 2007
- A Randomized, Placebo-controlled Study of Fentanyl Buccal Tablet for Breakthrough Pain in Opioid-treated Patients With CancerThe Clinical Journal of Pain, 2006
- Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus Oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 μg: A single-dose, randomized, open-label, three-period study in healthy adult volunteersClinical Therapeutics, 2006
- Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteersClinical Therapeutics, 2006
- Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl PharmacokineticsClinical Pharmacokinetics, 2006
- Fentanyl Effervescent Buccal TabletsAmerican Journal of Drug Delivery, 2006
- FentanylJournal of Pain and Symptom Management, 2005
- Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy VolunteersClinical Pharmacokinetics, 2005
- Buccal mucosa as a route for systemic drug delivery: a review.2000
- Breakthrough pain: characteristics and impact in patients with cancer painPain, 1999